deltatrials
Completed PHASE1/PHASE2 NCT02575859

Adjuvant HIPEC to Prevent Colorectal Peritoneal Metastases in High-risk Patients

Pilot Study of Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Colorectal Cancer at High Risk for the Development of Metachronous Peritoneal Metastases

Sponsor: Azienda Usl di Bologna

Conditions Colorectal Neoplasm Metastasis
Interventions adjuvant HIPEC surgery
Updated 5 times since 2017 Last updated: Oct 13, 2015 Started: Jan 31, 2006 Primary completion: Jun 30, 2010 Completion: Dec 31, 2011

Listed as NCT02575859, this PHASE1/PHASE2 trial focuses on Colorectal Neoplasm and Metastasis and remains completed. Sponsored by Azienda Usl di Bologna, it has been updated 5 times since 2006, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1_PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE1_PHASE2

    First recorded

Jan 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Azienda Usl di Bologna
  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Data source: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.